University of Ioannina
Μελέτη επιγενετικών μηχανισμών στη χημειοανθεκτικότητα του τριπλά αρνητικού καρκίνου του μαστού
Abstract
dc:descriptionBreast cancer is the most frequently diagnosed malignancy in women worldwide and the heterogeneity of the disease is an obstacle for the development of effective treatments that will lead to the definitive elimination of these tumors. Triple negative breast cancer (TNBC) is characterized by the absence of estrogen, progesterone and human epidermal growth factor 2 receptors, and is the most aggressive type of breast cancer with poor survival and prognosis. Due to the lack of identified molecular targets, chemotherapy is the standard treatment for TNBC, but, despite a good initial response, many patients will develop resistance and tumor recurrence. TNBC tumors possess a wide range of chemoresistance mechanisms,including deregulated epigenetic mechanisms. Understanding these mechanisms could lead to the development of new targeting approaches that may be more effective against chemoresistant cells. In the present study, we have developed and characterized two paclitaxel-resistant TNBC cell lines (SUM159 and BT-549) to investigate epigenetic mechanisms that may be implicated in the development of chemoresistance and identify potential targets. Characterization of resistant cell lines, including transcriptome analysis, revealed several of the "classical" mechanisms of chemoresistance. Over-expression of epigenetic regulators in chemoresistant cell lines, related to DNA methylation and histone deacetylation, lead to inhibition experiments of these processes. Our results showed that DNA methylation and histone deacetylation contribute to the chemoresistance of SUM159 and BT-549 cells, respectively. Analysis of chromatin accessibility by ATAC-sequencing demonstrated significant differences between parental and resistant cells. In the case of SUM159 PTX-res cells, changes in chromatin accessibility are accompanied by corresponding changes in H3K27ac levels,further supporting our hypothesis that the expression of the closest genes is under epigenetic regulation. Pathway enrichment analysis, after integration of RNA-seq, ATAC-seq and H3K27acChip seq data, showed that the Epithelial-to Mesenchymal Transition (EMT) was one of themost overrepresented biological processes in the SUM159 chemoresistant cells. ChIP-seq experiments for p63 transcription factor revealed the collapse of p63 cistrome in these cells, with a simultaneous reduction in chromatin accessibility. Typically, the closest genes which are downregulated in chemoresistant SUM159 cells, concern the regulation of an epithelial phenotype, in agreement with the main role of p63 as a master regulator of epidermal growth. The above results suggest, that the process of EMT, which is probably promoted by the suppression of p63, plays an important role in the chemoresistance of this subtype of TNBC. Targeted anti-EMT drugs could re-sensitize these cells to paclitaxel.
Degree
thesis:*- Grantor dc:publisher
- University of Ioannina
- Year dc:date
- 2023
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Kordias, Dimitrios
- Κορδιάς, Δημήτριος
Subjects
dc:subject × 12- Τριπλά αρνητικός καρκίνος μαστού
- Χημειοανθεκτικότητα
- Επιγενετική
- Triple negative breast cancer
- Chemoresistance
- Epigenetics
- Άλλες Ιατρικές Επιστήμες
- Ιατρική και Επιστήμες Υγείας
- Ιατρική έρευνα και Πειραματική ιατρική
- Other Medical Sciences
- Medical and Health Sciences
- Research and Experimental medicine
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/55069